Nuo Therapeutics, Inc. (AURX) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Nuo Therapeutics, Inc. (AURX).

Download OTCGems on Google Play Download OTCGems on the App Store

Equity Overview

Price & Market Data

Price: $1.60

Daily Change: $0.00 / 0.00%

Daily Range: $0 - $0

Market Cap: $74,836,512

Daily Volume: 0

Performance Metrics

1 Week: 1.27%

1 Month: -11.60%

3 Months: -30.13%

6 Months: -3.50%

1 Year: 34.45%

YTD: -20.00%

Company Details

Employees: 9

Sector: Health technology

Industry: Medical specialties

Country:

Details

Nuo Therapeutics, Inc. operates as a regenerative therapies company that develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing in the United States. The company offers the Aurix System, which separates autologous blood to produce a platelet-based therapy for the chronic wound care market. It serves hospital outpatient wound care clinics and other private practice physicians treating chronic wounds. The company was formerly known as Cytomedix, Inc. and changed its name to Nuo Therapeutics, Inc. in November 2014. Nuo Therapeutics, Inc. was incorporated in 1998 and is based in Houston, Texas.

Selected stocks

AMTRUST FINANCIAL SERVICES INC 7.75% DEP SHS REPSTG 1/40 NON-CUM PFD E (AFSIM)

AMTRUST FINANCIAL SERVICES INC DEP SHS REPSTG 1/40TH PFD B (AFSIB)

AMTRUST FINANCIAL SERVICES INC 6.75% NON-CUM PFD SER A USD25 (AFSIA)